Aurigene (a wholly owned subsidiary of Dr. Reddy’s Laboratories) is a leading Contract Research, Development, and Manufacturing Organization (CRDMO) with over two decades of experience in drug discovery and development. Aurigene’ s mission is to accelerate the development and delivery of innovative medicines to patients through an efficient drug discovery process. In alignment with this mission, Aurigene added the following tools to its service offerings:
- Computer Aided Drug Design (CADD) & Bioinformatics: A unique blend of traditional CADD, physics-based simulation, and bioinformatics applications
- Aurigene.AI: An AI-assisted drug discovery platform
- Aurimine: A virtual database comprising over 12 billion compounds
These innovations reinforce Aurigene’ s commitment to advancing drug discovery and bringing innovative medicines to realization.
Aurigene.AI features a meticulously curated compound database validated with structure normalization rules, continuously expanding using both in-house and public domain information. This robust database—currently containing 180 million compounds and 1.6 million validated bioassay data points—serves as a powerful search engine and training ground for AI algorithms. It is searchable via structure, property, or semantic queries to extract relevant information for specific purposes.
Aurigene.AI also allows extensive customization by incorporating multiple AI models into a single interface. It serves as a one-stop shop for a wide variety of top-tier predictive and generative AI models, alongside computational and CADD models. As of now, the platform includes 11 generative AI models, 4 predictive AI models, and 8 computational/CADD models. This modular and embedded design enables Aurigene’ s scientific experts to cherry-pick the right combination of models for targeted applications.
Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.